AuntiS

Same. We don't select K negative units once off the dara. Here in Canada, all our units are K typed by Canadian Blood Services. It wouldn't necessarily be more work to select K neg units, but we feel it isn't needed.

We share an LIS with a couple of other hospitals. We allow those previous blood groups to be the confirmation sample. We have access to a validated computer system that pulls results from other hospital LIS systems and matches using a unique ID (here in Ontario Canada it is the OHIP number). Names/DOB are double checked. We allow those for the second blood group as well. All our labs are accredited. I'm not sure what the difference between using the other hospital result in the LIS vs the other validated computer system would be. Also... my experience has been that blood tes

In Canada, all blood components and blood products (derivatives) require informed consent.

Here in Canada, the same sample can be retested IF the sample was collected using positive patient identification. So, here in our lab, we are super lucky because we have MLA who perform phlebotomy on 95% of the patients (some are nurse collected in the ED and ICU). Our MLA use positive patient identification technology (Mobilab). We allow for the retesting of those samples. Anyone else needs a new sample - which we order for lab collection, thus avoiding the workarounds where a second sample is drawn at the same time as the first but tucked away until needed. We also allow the pr

I'm so jealous - all these labs where the KB is performed in hematology! Here ours are done in the BB. To be fair, we are a core lab, so the staff performing the test are the same. I would just rather not own the test and all the competency that comes with it

We have been using a Bio-Rad IH-500 (and a SAXO as backup) for about a year now. Very happy with them. They work with the IH-Com that serves as a command centre for both and as middleware. We also use the antibody software and upload our QC to Unity. (We were manual gel/tube prior). sandra

Thanks Ensis01! I haven't even gotten that far yet - so I didn't know that the concentration of DTT is different :) s

When I was trained (many years ago!) we used +/- for microscopic tube reactions. Now, I encourage MLT to only use the microscope if they are looking to verify a mixed field or rouleaux. I suppose there could be other rare times to use a microscope - like an anti-Sda? But generally - no microscope. But they love the microscope...

I'm also developing a procedure for DTT treated cells. Can I assume that the DTT treated cells can be used to help ID antibodies other than daratumumab without additional validation? I am intrigued by the use of DTT for differentiation between IgG and IgM antibodies but I don't think we will go forward with it here at our community hospital

We do the same as Nikki. If an eluate is needed, an acid elution is done. No LUI freeze on the menu. sandra

Nikki - my calendar says it is 4am to 5:30am here! I hope it is available as a recording! sandra

Is it possible you have someone new who is not cancelling the units properly? s

It's an interesting idea - one motivated I suspect to provide a more attractive product to the hospital? But retyping in the hospital also theoretically covers any errors in donor entry into the hospital LIS. sandra

I've uploaded a Canadian Report from earlier this year that you may find interesting. Pages 11-12 have discussion and recommendations. Some of the discussion includes the following: Unnecessary testing:  Performing mid-pregnancy screens on Rh positive mothers  Testing DATs for all cords, or from all group O mothers or all Rh negative mothers, regardless of hemolysis indications sandra Obstetrical and Pedatric report -COPTN-Survey-Report-2019.pdf.pdf

We have a log book and a white board. The log book is a daily calendar and it is for more date specific items (i.e. order a specific product on that day) The white board is for more general or urgent items - something that doesn't fit on a day or would span over a longer period of time (i.e. shortage of a product). sandra